Author name: ASolia

Axxam enters CNS partnership with Lundbeck for Lead Identification

Leave a Comment / News / ASolia

Example single news

Axxam enters CNS partnership with Lundbeck for Lead Identification Read More »

Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions

Leave a Comment / News / ASolia

Example single news

Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions Read More »

Nanion User Meeting

Events / ASolia

24-25 October 2023 – Munich, Germany

Nanion User Meeting Read More »

Elrig Drug Discovery

Events / ASolia

18-19 October 2023 – Liverpool, UK

Elrig Drug Discovery Read More »

BioJapan

Events / ASolia

11-13 October 2023 – Yokohama, Japan

BioJapan Read More »

Alzheimer’s disease and Parkinson’s disease Conference

RESOLUTE: Unlocking Transporters For Drug Discovery

Events / ASolia

27-29 September 2023 – Vienna, Austria

RESOLUTE: Unlocking Transporters For Drug Discovery Read More »

DOT – Discovery on Target

Events / ASolia

25-28 September 2023 – Boston, USA

DOT – Discovery on Target Read More »

Arturo Falaschi Conference on TDP-43 function and dysfunction in disease

Events / ASolia

6-8 September 2023 – Trieste, Italy

Arturo Falaschi Conference on TDP-43 function and dysfunction in disease Read More »

Ciriaco Maraschiello joins Axxam as Chief Operating Officer

Leave a Comment / News / ASolia

5 July 2023

Ciriaco Maraschiello joins Axxam as Chief Operating Officer Read More »

FDSS User Meeting

Events / ASolia

29 June 2023 – Leuven, Belgium

FDSS User Meeting Read More »